These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9713914)

  • 21. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.
    Webberley JM; Matthews RS; Andrews JM; Wise R
    Eur J Clin Microbiol; 1987 Oct; 6(5):587-9. PubMed ID: 2449348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.
    Notomi T; Ikeda Y; Nagayama A
    Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
    Kohlhoff SA; Roblin PM; Reznik T; Hawser S; Islam K; Hammerschlag MR
    Antimicrob Agents Chemother; 2004 May; 48(5):1885-6. PubMed ID: 15105151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
    Lee CK; Bowie WR; Alexander ER
    Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of dirithromycin against Chlamydia trachomatis.
    Segreti J; Kapell KS
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
    O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN
    Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ofloxacin against Chlamydia trachomatis.
    Schachter J; Moncada JV
    Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
    Madhavan HN; Roy S; Malathy J
    Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
    Hartinger A; Korting HC; Neubert U; Blaufuss H
    Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin.
    Chiarini F; Mansi A; Tomao P; Gentile V; De Marco F; Brunori S; Wongher L; Di Silverio F
    J Chemother; 1994 Aug; 6(4):238-42. PubMed ID: 7830100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.
    Suchland RJ; Geisler WM; Stamm WE
    Antimicrob Agents Chemother; 2003 Feb; 47(2):636-42. PubMed ID: 12543671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of ofloxacin against Chlamydia trachomatis.
    Sambri V; Rumpianesi F; Xerri L; Cevenini R
    J Chemother; 1989 Aug; 1(4):231-2. PubMed ID: 2809689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
    Cao W; Liu L; Tong MH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibilities of Chlamydia trachomatis isolated from the urethra and pharynx of Japanese males.
    Kai S; Wada K; Sadahira T; Araki M; Ishii A; Watanabe T; Monden K; Uno S; Araki T; Nasu Y
    J Infect Chemother; 2017 Aug; 23(8):512-516. PubMed ID: 28476331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.